Cited 0 time in
High incidence of hepatitis B viral reactivation in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 엄지은 | - |
| dc.date.accessioned | 2021-08-02T16:33:50Z | - |
| dc.date.available | 2021-08-02T16:33:50Z | - |
| dc.date.issued | 2018-12-02 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/22710 | - |
| dc.title | High incidence of hepatitis B viral reactivation in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 60th American Society of Hematology Annual Meeting and Exposition | - |
| dc.citation.conferencePlace | San Diego Covention Center, San Diego, CA, USA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
